Literature DB >> 27927321

Does Thoracic Hypokyphosis Matter in Lenke Type 1 Adolescent Idiopathic Scoliosis?

Steven D Glassman1, Daniel J Sucato2, Leah Y Carreon3, James O Sanders4, Michael G Vitale5, Lawrence G Lenke6.   

Abstract

STUDY
DESIGN: We analyzed a prospective cohort of Lenke 1ABC adolescent idiopathic scoliosis (AIS) patients based on differences in T5-T12 sagittal alignment.
OBJECTIVE: Our objective was to determine whether patients with hypokyphotic scoliosis demonstrate unique characteristics in terms of baseline health status and response to surgery. BACKGROUND
SUMMARY: Right thoracic AIS often presents as a hypokyphotic scoliosis, with rotatory deformity resulting in a diminution of the normal thoracic kyphosis. The perceived importance is indicated by the inclusion of a sagittal plane modifier within Lenke's classification system for AIS and studies examining reduction strategies to restore thoracic kyphosis.
METHODS: We grouped patients based on thoracic kyphosis, measured from T5 to T12, as either less than 10° (hypokyphotic) or greater than or equal to 10° (normal/kyphotic). We used Student t test for independent samples to compare continuous variables between the hypokyphotic and normal/kyphotic groups.
RESULTS: There was a significant difference in age between groups (mean age, 14.9 years in the hypokyphotic group versus 13.4 years in the normal/kyphotic group; p = .007). Differences in baseline health status measures were statistically significant but small. Hypokyphotic patients reported less pain than normal/kyphotic patients, with a mean Scoliosis Research Society (SRS) Pain score of 4.15 versus 4.03 (p = .044), better SRS Mental Domain scores (4.06 vs. 3.92; p = .026), and better SRS Total scores (3.92 vs. 3.83, p = .027). The hypokyphotic group also had better SRS Appearance (3.36 vs. 3.30) and Activity scores (4.20 vs. 4.13), but these differences did not reach statistical significance.
CONCLUSIONS: There were no differences in baseline or 2-year postoperative outcome scores in Lenke 1 AIS patients with hypokyphosis compared with patients with normal sagittal alignment. Maintenance of or restoration to normal kyphosis in hypokyphotic patients with Lenke 1 AIS may not improve clinical outcome compared with patients who remain lordotic after surgical correction.
Copyright © 2013 Scoliosis Research Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent idiopathic scoliosis; Health status; SRS-22; Sagittal alignment; Thoracic hypokyphosis; Thoracic lordosis

Year:  2013        PMID: 27927321     DOI: 10.1016/j.jspd.2012.09.001

Source DB:  PubMed          Journal:  Spine Deform        ISSN: 2212-134X


  4 in total

1.  Influence of screw density on thoracic kyphosis restoration in hypokyphotic adolescent idiopathic scoliosis.

Authors:  Ming Luo; Honghui Jiang; Wengang Wang; Ning Li; Mingkui Shen; Peng Li; Genzhong Xu; Lei Xia
Journal:  BMC Musculoskelet Disord       Date:  2017-12-13       Impact factor: 2.362

2.  Normal Age-Adjusted Sagittal Spinal Alignment Is Achieved with Surgical Correction in Adolescent Idiopathic Scoliosis.

Authors:  Subaraman Ramchandran; Norah Foster; Akhila Sure; Thomas J Errico; Aaron J Buckland
Journal:  Asian Spine J       Date:  2017-10-11

3.  A Retrospective Study of Factors Associated with Restoration of Thoracic Kyphosis in 43 Patients with Adolescent Idiopathic Scoliosis with Lenke Type 1 Curvature.

Authors:  Liyi Chen; Chong Liu; Shian Liao; Chaojie Yu; Tuo Liang; Zhaojie Qin; Shengsheng Huang; Xuhua Sun; Ming Yi; Zhaojun Lu; Zequn Wang; Guoyong Xu; Zide Zhang; Jiarui Chen; Jie Jiang; Xinli Zhan
Journal:  Med Sci Monit       Date:  2021-02-20

4.  Thoracic kyphosis in light of lumbosacral alignment in thoracic adolescent idiopathic scoliosis: recognition of thoracic hypokyphosis and therapeutic implications.

Authors:  Takuya Iimura; Haruki Ueda; Satoshi Inami; Hiroshi Moridaira; Daisaku Takeuchi; Hiromichi Aoki; Hiroshi Taneichi
Journal:  BMC Musculoskelet Disord       Date:  2022-05-03       Impact factor: 2.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.